Gene · 7538
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The characteristic of stem-related genes with pancreatic carcinoma cell after irradiation. | Heliyon | 2023 | 37484310 | PubTator, text mining | PubMed |
| Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation. | Front Immunol | 2023 | 37483631 | PubTator, text mining | PubMed |
| ThPOK is a critical multifaceted regulator of myeloid lineage development. | Nat Immunol | 2023 | 37474652 | PubTator, text mining | PubMed |
| Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells. | Front Pharmacol | 2023 | 37469866 | PubTator, text mining | PubMed |
| Peripheral blood biomarkers predict viral rebound following antiretroviral therapy discontinuation in SIV-infected, early ART-treated rhesus macaques. | Cell Rep Med | 2023 | 37467721 | PubTator, text mining | PubMed |
| RNA-binding proteins that are highly expressed and enriched in healthy cartilage but suppressed in osteoarthritis. | Front Cell Dev Biol | 2023 | 37457300 | PubTator, text mining | PubMed |
| Transcriptomic analysis of spinal cord regeneration after injury in Cynops orientalis. | Neural Regen Res | 2023 | 37449639 | PubTator, text mining | PubMed |
| The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas-New Potential Therapeutic Approach-A Systematic Review. | Int J Mol Sci | 2023 | 37446128 | PubTator, text mining | PubMed |
| The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target. | Cancer Cell Int | 2023 | 37438760 | PubTator, text mining | PubMed |
| Identification of cell death-related biomarkers and immune infiltration in ischemic stroke between male and female patients. | Front Immunol | 2023 | 37435058 | PubTator, text mining | PubMed |
| Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA. | Acta Pharm Sin B | 2023 | 37425040 | PubTator, text mining | PubMed |
| Gene expression profiling unveils the temporal dynamics of CIGB-300-regulated transcriptome in AML cell lines. | BMC Genomics | 2023 | 37400761 | PubTator, text mining | PubMed |
| Comprehensive transcript-level analysis reveals transcriptional reprogramming during the progression of Alzheimer's disease. | Front Aging Neurosci | 2023 | 37396652 | PubTator, text mining | PubMed |
| Identification and analysis of cellular senescence-associated signatures in diabetic kidney disease by integrated bioinformatics analysis and machine learning. | Front Endocrinol (Lausanne) | 2023 | 37396184 | PubTator, text mining | PubMed |
| Retracted: ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress. | Oxid Med Cell Longev | 2023 | 37388511 | PubTator, text mining | PubMed |
| Identification of PDK4 as Hub Gene for Diabetic Nephropathy Using Co-Expression Network Analysis. | Kidney Blood Press Res | 2023 | 37385224 | PubTator, text mining | PubMed |
| The Roles of Zinc Finger Proteins in Colorectal Cancer. | Int J Mol Sci | 2023 | 37373394 | PubTator, text mining | PubMed |
| ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries. | Int J Mol Sci | 2023 | 37373168 | PubTator, text mining | PubMed |
| The Prolyl Oligopeptidase Inhibitor KYP-2047 Is Cytoprotective and Anti-Inflammatory in Human Retinal Pigment Epithelial Cells with Defective Proteasomal Clearance. | Antioxidants (Basel) | 2023 | 37372009 | PubTator, text mining | PubMed |
| Identification of Glucocorticoid Receptor Target Genes That Potentially Inhibit Collagen Synthesis in Human Dermal Fibroblasts. | Biomolecules | 2023 | 37371558 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7538/papers?page=18